Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naomi R Waterlow

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Jac-Antimicrobial Resistance|February 10, 2025
Observational study of antibiotic prescribing patterns by age and sex in primary care in England: why we need to take this variation into account to evaluate antibiotic stewardship and predict AMR variationNaomi R Waterlow, Tom Ashfield, Gwenan M Knight
Epidemics|April 10, 2021
Competition between RSV and influenza: Limits of modelling inference from surveillance dataNaomi R Waterlow, Stefan Flasche, Amanda Minter, et al.
BMC Medicine|August 9, 2023
Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccinesNaomi R Waterlow, Simon R Procter, Rosalind M Eggo, et al.
Wellcome Open Research|December 7, 2021
Estimating the duration of seropositivity of human seasonal coronaviruses using seroprevalence studiesEleanor M Rees, Naomi R Waterlow, , et al.
Plos Medicine|March 14, 2024
Antimicrobial resistance prevalence in bloodstream infection in 29 European countries by age and sex: An observational studyNaomi R Waterlow, Ben S Cooper, Julie V Robotham, et al.
Wellcome Open Research|August 9, 2024
MIC distribution analysis identifies differences in AMR between population sub-groupsJacob Wildfire, Naomi R Waterlow, Alastair Clements, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 7, 2021
How immunity from and interaction with seasonal coronaviruses can shape SARS-CoV-2 epidemiologyNaomi R Waterlow, Edwin van Leeuwen, Nicholas G Davies, et al.
Vaccine|August 26, 2023
The potential cost-effectiveness of next generation influenza vaccines in England and Wales: A modelling analysisNaomi R Waterlow, Simon R Procter, Edwin van Leeuwen, et al.
Frontiers in Public Health|October 26, 2020
Behavioral Change Towards Reduced Intensity Physical Activity Is Disproportionately Prevalent Among Adults With Serious Health Issues or Self-Perception of High Risk During the UK COVID-19 LockdownNina Trivedy Rogers, Naomi R Waterlow, Hannah Brindle, et al.
Epidemics|May 15, 2020
Tooling-up for infectious disease transmission modellingMarc Baguelin, Graham F Medley, Emily S Nightingale, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Jac-Antimicrobial Resistance|February 10, 2025
Observational study of antibiotic prescribing patterns by age and sex in primary care in England: why we need to take this variation into account to evaluate antibiotic stewardship and predict AMR variationNaomi R Waterlow, Tom Ashfield, Gwenan M Knight
Epidemics|April 10, 2021
Competition between RSV and influenza: Limits of modelling inference from surveillance dataNaomi R Waterlow, Stefan Flasche, Amanda Minter, et al.
BMC Medicine|August 9, 2023
Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccinesNaomi R Waterlow, Simon R Procter, Rosalind M Eggo, et al.
Wellcome Open Research|December 7, 2021
Estimating the duration of seropositivity of human seasonal coronaviruses using seroprevalence studiesEleanor M Rees, Naomi R Waterlow, , et al.
Plos Medicine|March 14, 2024
Antimicrobial resistance prevalence in bloodstream infection in 29 European countries by age and sex: An observational studyNaomi R Waterlow, Ben S Cooper, Julie V Robotham, et al.
Wellcome Open Research|August 9, 2024
MIC distribution analysis identifies differences in AMR between population sub-groupsJacob Wildfire, Naomi R Waterlow, Alastair Clements, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 7, 2021
How immunity from and interaction with seasonal coronaviruses can shape SARS-CoV-2 epidemiologyNaomi R Waterlow, Edwin van Leeuwen, Nicholas G Davies, et al.
Vaccine|August 26, 2023
The potential cost-effectiveness of next generation influenza vaccines in England and Wales: A modelling analysisNaomi R Waterlow, Simon R Procter, Edwin van Leeuwen, et al.
Frontiers in Public Health|October 26, 2020
Behavioral Change Towards Reduced Intensity Physical Activity Is Disproportionately Prevalent Among Adults With Serious Health Issues or Self-Perception of High Risk During the UK COVID-19 LockdownNina Trivedy Rogers, Naomi R Waterlow, Hannah Brindle, et al.
Epidemics|May 15, 2020
Tooling-up for infectious disease transmission modellingMarc Baguelin, Graham F Medley, Emily S Nightingale, et al.
Pageof 2